Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ascorbic acid + zinc
- Development stage
- Phase 3
- Lead developer
- INNventa Pharm
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
IMUNITINN C+Zn is a dietary supplement developed by INNventa Pharm, a pharmaceutical company based in Belgrade, Serbia. It contains a combination of Vitamin C (ascorbic acid) and Zinc, which are essential for the normal functioning of the immune system and the protection of cells from oxidative stress. The product is indicated for general immune support, the prevention of colds, flu, and chronic respiratory infections, as well as the reduction of fatigue and exhaustion. It also supports wound healing and collagen formation. IMUNITINN C+Zn is available in two forms: tablets and 'direct' oral sachets, and is distributed in Serbia and other Central and Eastern European markets.
- Brand names
- Imunitinn C + ZnImunitinn C + Zn direct
- Other names
- Vitamin C + Zinc
Beyond the preview
Go deeper on ascorbic acid + zinc.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ascorbic acid + zinc.